Skip to main content

Together we are beating cancer

Donate now

Cancer News

The latest news, analysis and opinion from Cancer Research UK

Institute

Showing 12 out of 45 results
Non small cell lung cancer cells stained in pleural effusion sample.

Researchers based at the Francis Crick Institute have published new results from TRACERx, revealing the secrets of how lung cancer can evolve, spread and resist treatment. Researchers based at the Francis Crick Institute have published new results from TRACERx, revealing the secrets of how lung cancer can evolve, spread and resist treatment.

by Jacob Smith | Analysis | 12 April 2023

12 April 2023

Melanoma cells viewed under the microscope

New results from the Cancer Research UK-funded PEACE study have revealed how some skin cancers stop responding to treatment at the end of life. New results from the Cancer Research UK-funded PEACE study have revealed how some skin cancers stop responding to treatment at the end of life.

by Jacob Smith | News | 29 March 2023

29 March 2023

Left to right: Emma Colliver, Dr William Hill and Dr Emilia Lim

We chatted to three researchers working on TRACERx, Dr Emilia Lim, Dr William Hill and Emma Colliver about their work, what a day in their lives looks like, and how their paths have led to where they are today.  We chatted to three researchers working on TRACERx, Dr Emilia Lim, Dr William Hill and Emma Colliver about their work, what a day in their lives looks like, and how their paths have led to where they are today. 

by Jacob Smith | Interview | 13 December 2022

13 December 2022

T cell

Researchers in Southampton have found a way to improve the effectiveness of immunotherapy in cancers that are resistant by repurposing existing drugs Researchers in Southampton have found a way to improve the effectiveness of immunotherapy in cancers that are resistant by repurposing existing drugs

by Jacob Smith | Analysis | 11 November 2022

11 November 2022

Today, we've announced TRACERx EVO, a new programme that builds on the discoveries made in the world’s largest long-term lung study, TRACERx.  Today, we've announced TRACERx EVO, a new programme that builds on the discoveries made in the world’s largest long-term lung study, TRACERx. 

by Kathryn Thompson | News | 9 November 2022

9 November 2022

A 3D illustration of cancer cells

Research from our Cambridge Institute has shown us that metastasis isn’t a process unique to cancer, revolutionising the way we think about cell dissemination.  Research from our Cambridge Institute has shown us that metastasis isn’t a process unique to cancer, revolutionising the way we think about cell dissemination. 

by Jacob Smith | Analysis | 18 October 2022

18 October 2022

A illustration of T cells, a type of immune cell attacking cancer

If we’re to reduce the risk of bowel cancer in people with IBD, we’re going to have to find a more effective treatment. And we may have done just that.  If we’re to reduce the risk of bowel cancer in people with IBD, we’re going to have to find a more effective treatment. And we may have done just that. 

by Jacob Smith | Analysis | 23 August 2022

23 August 2022

Dr Hugo De La Peña in front of University Hospital Southampton

Dr Hugo De La Peña, the face of our latest TV advert, explains how a second chance at life led to a career dedicated to curing cancer.   Dr Hugo De La Peña, the face of our latest TV advert, explains how a second chance at life led to a career dedicated to curing cancer.  

by Elisa Mitchell | Personal stories | 12 August 2022

12 August 2022

A photograph of a person holding a blood test

Our researchers at the University of Cambridge have found that patients who are at a higher risk of their lung cancer returning can be identified by a personalised blood test. Our researchers at the University of Cambridge have found that patients who are at a higher risk of their lung cancer returning can be identified by a personalised blood test.

by Graeme Sneddon | News | 1 April 2022

1 April 2022